Summary
- Current Price
- As of today, NBP price is $2.43, down -1.22% on
- Current Price All-Time High
- NBP price is currently -97.15% below its historical high of $85.40 set on
- Market Cap
- NBP current market cap is $280M, up +340.97% over the past 365 days
- PE Ratio
- NBP PE ratio is unknown
- Revenue
- NBP current annual revenue is $0.00, down -100.00% year-over-year
- Next Earnings
- The next earnings release for NBP is on
Profile
| Metric | Value |
|---|---|
| Full Name | NovaBridge Biosciences |
| Ticker | NASDAQ: NBP |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | i-mabbiopharma.com |
| Employees | 32 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $2.43 | ||
| Price, 1D Change | -1.22% | |
| $280M | ||
| - | ||
| - | ||
| 0.82 | ||
| $0 | ||
| Revenue, 1Y Change | -100.00% | |
| -$0.70 | ||
| EPS, 1Y Change | +72.03% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | IMAB | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.70 | ||
| EPS Estimate | -$0.19 | |
| EPS Est. Change | +73.47% | |
| $0.00 | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| $2.43 | ||
| Price Target | - | $8.50 |
| Price Tgt. Change | - | +249.79% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.19 | N/A | - | |
| -$0.23 | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +212.34% | ||
| -29.77% | ||
| +340.97% | ||
| -2.96% | ||
| -100.00% | ||
| -100.00% | ||
| +72.03% | ||
| +85.35% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $2.43 | ||
| $3.66 | ||
| SMA 200 vs Price | +50.50% | |
| $3.18 | ||
| SMA 50 vs Price | +30.91% | |
| 0.82 | ||
| $0.26 | ||
| 36.09 | ||
| 93.59% | ||
| 129.01% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$0.70 | ||
| -$978.50K | ||
| - | ||
| -$51.45M | ||
| - | ||
| -$49.72M | ||
| - | ||
| -$50.47M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.02 | ||
| 20.90 | ||
| 20.90 | ||
| - | ||
| - | ||
| 6.28 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.08 | ||
| -2.67 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $201.16M | ||
| $173.40M | ||
| $212.68M | ||
| $176.69M | ||
| $11.52M | ||
| $8.45M | ||
| $3.88M | ||
| $816.00K | ||
| $0.00 |
Expenses
| Metric | Date | Value |
|---|---|---|
| $49.72M | ||
| $50.47M | ||
| $978.50K | ||
| $29.67M | ||
| $978.50K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$52.11M | ||
| -$136.08M | ||
| -$923.50K | ||
| $48.00K | ||
| -$52.16M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| BTIG | → | |
| Leerink Partners | ||
| BTIG | → | |
| BTIG | ||
| Needham | → | |
| HC Wainwright & Co. | → | |
| Needham | → |
Analyst sentiment
Institutional ownership
Screeners with NBP
FAQ
What is the ticker symbol for NovaBridge Biosciences?
The ticker symbol for NovaBridge Biosciences is NASDAQ:NBP
Does NovaBridge Biosciences pay dividends?
No, NovaBridge Biosciences does not pay dividends
What sector is NovaBridge Biosciences in?
NovaBridge Biosciences is in the Healthcare sector
What industry is NovaBridge Biosciences in?
NovaBridge Biosciences is in the Biotechnology industry
What country is NovaBridge Biosciences based in?
NovaBridge Biosciences is headquartered in United States
When did NovaBridge Biosciences go public?
NovaBridge Biosciences initial public offering (IPO) was on January 17, 2020
Is NovaBridge Biosciences in the S&P 500?
No, NovaBridge Biosciences is not included in the S&P 500 index
Is NovaBridge Biosciences in the NASDAQ 100?
No, NovaBridge Biosciences is not included in the NASDAQ 100 index
Is NovaBridge Biosciences in the Dow Jones?
No, NovaBridge Biosciences is not included in the Dow Jones index
When was NovaBridge Biosciences last earnings report?
NovaBridge Biosciences's most recent earnings report was on December 18, 2025
When does NovaBridge Biosciences report earnings?
The next expected earnings date for NovaBridge Biosciences is April 6, 2026
Data Sources & References
- NBP Official Website www.i-mabbiopharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1778016/000119312525323791/0001193125-25-323791-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1778016/000095017025050344/0000950170-25-050344-index.htm
- NBP Profile on Yahoo Finance finance.yahoo.com/quote/NBP
- NBP Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nbp